Cite

    Kitajima, S. et al. (2023). Long‐term prognosis of focal segmental glomerulosclerosis treated with therapeutic low‐density lipoprotein‐apheresis in patients with severe kidney dysfunction and proteinuria. Rheumatology & autoimmunity. 3 (1), pp. 35-42. [Online].